Late complications of the new coronavirus infection: a clinical case
https://doi.org/10.18093/0869-0189-2023-33-1-102-108
Abstract
According to the literature, exudative pleurisy and pericarditis are considered rare complications of the new coronavirus infection. This estimation can be explained by the fact that statistical studies cover mainly the hospital treatment of this disease. The true frequency of these complications and their consequences are not fully understood.
Aim. The study of late complications of the new coronavirus infection in the form of pleurisy and pericarditis.
Conclusion. In our case, a 62-year-old patient with the new coronavirus infection confirmed by polymerase chain reaction, severe bilateral polysegmental viral pneumonia, CT3, 60% on day 43 after the onset of clinical symptoms, was found to have manifestations of pleurisy and pericarditis during outpatient treatment. Cardiac MRI is the most informative method for detecting small pericardial and pleural effusions. The diagnostic capabilities of this method are superior to ultrasounography of the heart and pleural cavities and computed tomography of the lungs. Administration of colchicine 1.0 g per day for 1 month allowed not only to the elimination of pericarditis and pleurisy, but also the reduction of pressure in the right ventricle, probably by reducing the damage to the pulmonary parenchyma.
Keywords
new coronavirus infection,
COVID-19,
pericardial and pleural effusion,
bilateral polysegmental viral pneumonia,
colchicine
Supporting agencies: The study had no funding or sponsorship
About the Authors
S. A. Chepurnenko
Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University, Healthcare Ministry of Russia; State Budgetary Institution of the Rostov region Rostov Regional Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Svetlana A. Chepurnenko - Doctor of Medicine, Associate Professor, Department of General Medical Practice (Family Medicine) with Courses in Geriatrics and Physiotherapy, Rostov State Medical University; Cardiologist, Rostov RCH.
Per. Nahichevanskiy 29, Rostov-na-Donu, 344022; ul. Blagodatnaya 170, Zapadnyy zhiloy massiv, Rostov-na-Donu, 344015; tel.: (863) 222-04-23
Competing Interests:
The authors declare no conflict of interest
G. V. Shavkuta
Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University, Healthcare Ministry of Russia
Russian Federation
Competing Interests:
Russian Federation
Galina V. Shavkuta - Doctor of Medicine, Professor, Head of the Department of General Medical Practice (Family Medicine) with Courses in Geriatrics and Physiotherapy.
Per. Nahichevanskiy 29, Rostov-na-Donu, 344022; tel.: (863) 222-04-23
Competing Interests:
The authors declare no conflict of interest
A. A. Demidova
Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University, Healthcare Ministry of Russia
Russian Federation
Competing Interests:
Russian Federation
Anna A. Demidova - Laboratory Assistant, Department of General Medical Practice (Family Medicine) with Courses in Geriatrics and Physiotherapy.
Per. Nahichevanskiy 29, Rostov-na-Donu, 344022; tel.: (863) 222-04-23
Competing Interests:
The authors declare no conflict of interest
References
1. Mehta P., McAuley D.F., Brown M. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395 (10229): 1033–1034. DOI: 10.1016/S0140-6736(20)30628-0.
2. Caso F., Costa L., Ruscitti P. et al. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun. Rev. 2020; 19 (5): 102524. DOI: 10.1016/j.autrev.2020.102524.
3. Khristenko E., von Stackelberg O., Kauczor H.U. et al. [CT-patterns in COVID-19 associated pneumonia – unification of radiological reports based on glossary of Fleischner society]. REJR. 2020; 10 (1): 16–26. DOI: 10.21569/2222-7415-2020-10-1-16-26 (in Russian).
4. Li X., Wang L., Yan S. et al. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. Int. J. Infect. Dis. 2020; 94: 128–132. DOI: 10.1016/j.ijid.2020.03.053.
5. Akhmerov A., Marbán E. COVID-19 and the Heart. Circ. Res. 2020; 126 (10): 1443–1455. DOI: 10.1161/circresaha.120.317055.
6. Huang C., Wang Y., Li X. et al. Сlinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497‒506. DOI: 10.1016/S0140-6736(20)30183-5.
7. Mareev V.Yu., Orlova Ya.A., Pavlikova E.P. et al. [Steroid pulse-therapy in patients with coronavirus pneumonia (COVID-19), systemic inflammation and risk of venous thrombosis and thromboembolism (WAYFARER Study)]. Kardiologiia. 2020; 60 (6): 15–29. DOI: 10.18087/cardio.2020.6.n1226 (in Russian).
8. Li B., Yang J., Zhao F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 2020; 109 (5): 531‒538. DOI: 10.1007/s00392-020-01626-9.
9. Zhu H., Rhee J.W., Cheng P. et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr. Cardiol. Rep. 2020; 22 (5): 32. DOI: 10.1007/s11886-020-01292-3.
10. Williams B., Zhang Y. Hypertension, rennin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet. 2020; 395 (10238): 1671–1673. DOI: 10.1016/s0140-6736(20)31131-4.
11. Starostin D.O., Kuzovlev A.N. [The role of lung ultrasound in the COVID-19]. Vestnik anesteziologii i reanimatologii. 2020; 17 (4): 23– 30. DOI: 10.21292/2078-5658-2020-17-4-23-30 (in Russian).
12. Zhou S., Wang Y., Zhu T., Xia L. CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. Am. J. Roentgenol. 2020; 214 (6): 1287–1294. DOI: 10.2214/AJR.20.22975.
13. Vinokurov A.S., Belenkaya O.I., Zolotova E.A. et al. [Differential diagnosis of bilateral lungs opacities in the hospital for admission of community-acquired pneumonia – not only COVID-19]. Meditsinskaya vizualizatsiya. 2020; 24 (2): 78–95. DOI: 10.24835/1607-0763-2020-2-78-95 (in Russian).
14. Lesnyak V.N., Zhuravleva V.A., Averyanov A.V. [The capabilities of MRI in the lung lesions diagnosis in patients with COVID-19]. Klinicheskaya praktika. 2020; 11 (2): 51–59. DOI: 10.17816/clinpract34843 (in Russian).
15. Soldati G., Smargiassi A., Inchingolo R. et al. Is there a role for lung ultrasound during the COVID-19 pandemic? J. Ultrasound Med. 2020; 39 (7): 1459–1462. DOI: 10.1002/jum.15284.
16. Shi H., Han X., Jiang N. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 2020; 20 (4): 425–434. DOI: 10.1016/S1473-3099(20)30086-4.
17. Li K., Wu J., Wu F. et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest. Radiol. 2020; 55 (6): 327–331. DOI: 10.1097/RLI.0000000000000672.
18. Grinevich V.B., Gubonina I.V., Doshchitsin V. L. et al. [Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020]. Kardiovaskulyarnaya terapiya i profilaktika. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 (in Russian).
19. Lutschinger L.L., Rigopoulos A.G., Schlattmann P. et al. Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome. BMC Cardiovasc. Disord. 2019; 19 (1): 207. DOI: 10.1186/s12872-019-1190-4.
20. Adler Y., Charron P., Imazio M. et al. [2015 ESC guidelines for the diagnosis and management of pericardial diseases]. Rossiyskiy kardiologicheskiy zhurnal. 2016; (5): 117–162. DOI: 10.15829/1560-4071-2016-5-117-162 (in Russian).
Supplementary files
Review
For citations:
Chepurnenko S.A., Shavkuta G.V., Demidova A.A. Late complications of the new coronavirus infection: a clinical case. PULMONOLOGIYA. 2023;33(1):102-108. (In Russ.) https://doi.org/10.18093/0869-0189-2023-33-1-102-108
Views:
1742
Email this article 